Frequency (%) | |||||
---|---|---|---|---|---|
Task | Always | Most of the time | About half the time | Sometimes | Never |
Conduct a feasibility analysis of any type | 18.1 | 27.3 | 9.1 | 45.5 | 0 |
Consider disease frequency in the general veterinary population | 36.4 | 54.6 | 0 | 9.1 | 0 |
Consider disease frequency Hospital or program-specific caseload | 45.5 | 45.5 | 4.5 | 4.5 | 0 |
Consider existing treatment patterns or guidelines | 36.4 | 45.5 | 0 | 18.2 | 0 |
Consider availability of alternative drugs or treatments | 18.2 | 54.5 | 0 | 27.3 | 0 |
Consider presence of competing trials within the hospital | 23.8 | 33.3 | 9.5 | 28.6 | 4.8 |
Consider presence of competing trials within the geographical region | 0 | 23.7 | 4.6 | 59.1 | 13.6 |
Complete a sample size determination prior to initiating a study | 27.3 | 40.9 | 9.1 | 18.2 | 4.6 |
Use an electronic laboratory note book or study record for clinical data capture | 9.1 | 18.2 | 13.6 | 54.6 | 4.6 |
Complete a formal GCP training program prior to initiation of their first clinical trial | 13.6 | 0 | 4.6 | 63.6 | 18.2 |
Complete a formal RCR training program prior to initiation of their first clinical trial | 36.4 | 27.3 | 9.1 | 27.3 | 0 |
Complete formal budget training program prior to initiation of their first clinical trial | 0 | 4.6 | 4.6 | 45.5 | 45.5 |
Complete a formal grants management training program prior to initiation of their first clinical trial | 0 | 0 | 4.6 | 54.6 | 41.0 |
Read and/or sign a PI agreement dealing with the Institution’s policies procedures and expectations for investigators participating in veterinary clinical research | 9.1 | 9.1 | 4.6 | 40.9 | 36.4 |
Utilize a data safety monitoring committee or similar entity | 13.6 | 4.6 | 0 | 54.6 | 27.3 |